Introduction Early Access Programs, also known as special access programs, give patients access to m...
Read moreAn affordable and sustainable market access landscape is key to ensure patient access to life-saving...
Read moreWe explore why combination pricing is an issue in the oncology space and why payers and manufacturer...
Read moreBeyond the regulatory level, a well-recognised challenge for companies launching drugs in orphan dis...
Read moreIn December 2021, China once again updated its National Reimbursed Drugs List (NRDL).
Read moreThis educational blog explores what PROs are, explains why they of growing importance in the digital...
Read moreAdvanced therapy medicinal products (ATMPs) are medicinal products for human use that are based on l...
Read moreNICE require a broad range of evidence to be included within the reimbursement dossier, including cl...
Read moreThis reforms have been welcomed by the industry as they should support faster access to medicines as...
Read moreThe 2021 Social Security Law made provision for overhauling the early scheme in France. As of 1st Ju...
Read more